BITTONI, ALESSANDRO
 Distribuzione geografica
Continente #
NA - Nord America 2.326
EU - Europa 1.229
AS - Asia 552
SA - Sud America 169
AF - Africa 89
Continente sconosciuto - Info sul continente non disponibili 3
Totale 4.368
Nazione #
US - Stati Uniti d'America 2.319
IT - Italia 263
SG - Singapore 196
UA - Ucraina 196
SE - Svezia 159
BR - Brasile 157
DE - Germania 141
CN - Cina 126
IE - Irlanda 118
RU - Federazione Russa 103
TR - Turchia 97
FI - Finlandia 85
DK - Danimarca 72
HK - Hong Kong 58
CI - Costa d'Avorio 56
KR - Corea 39
GB - Regno Unito 31
MA - Marocco 23
FR - Francia 21
NL - Olanda 21
IN - India 14
BD - Bangladesh 8
BE - Belgio 8
DZ - Algeria 5
CO - Colombia 4
CZ - Repubblica Ceca 4
JP - Giappone 4
VN - Vietnam 4
AR - Argentina 3
EU - Europa 3
CA - Canada 2
EC - Ecuador 2
PL - Polonia 2
RO - Romania 2
VE - Venezuela 2
ZA - Sudafrica 2
AE - Emirati Arabi Uniti 1
AO - Angola 1
AT - Austria 1
AZ - Azerbaigian 1
BY - Bielorussia 1
CL - Cile 1
CR - Costa Rica 1
DO - Repubblica Dominicana 1
EG - Egitto 1
ET - Etiopia 1
HN - Honduras 1
IQ - Iraq 1
JM - Giamaica 1
KG - Kirghizistan 1
MX - Messico 1
PK - Pakistan 1
RS - Serbia 1
SA - Arabia Saudita 1
Totale 4.368
Città #
Chandler 286
Jacksonville 214
Fairfield 210
Ashburn 165
Wilmington 134
Boardman 118
Dublin 118
Woodbridge 103
Singapore 99
Ann Arbor 95
New York 93
Seattle 92
Houston 85
Des Moines 74
Cambridge 72
Centro 67
Hong Kong 58
Abidjan 56
Lawrence 47
Princeton 47
San Mateo 47
Munich 45
The Dalles 33
Turin 33
Turku 32
Beijing 26
Moscow 23
San Diego 18
Helsinki 15
London 10
Los Angeles 9
Pune 9
Brussels 8
Guangzhou 7
Rio de Janeiro 7
Rome 7
Washington 7
Wuhan 7
Wuxi 7
Belo Horizonte 6
Cagliari 6
Curitiba 6
Milan 6
San Francisco 6
Santa Clara 6
Atlanta 5
Dallas 5
Amsterdam 4
Bogotá 4
Brasília 4
Chicago 4
Columbus 4
Falls Church 4
New Bedfont 4
Olomouc 4
Prescot 4
Shenzhen 4
São Paulo 4
Yiwu 4
Betim 3
Brooklyn 3
Cupra Marittima 3
Fermignano 3
Florence 3
Isola Rizza 3
Izmir 3
Jinan 3
Kilburn 3
Modena 3
Nanjing 3
Norwalk 3
Nuremberg 3
Rio Grande 3
Shanghai 3
Stockholm 3
Torre Del Greco 3
Ancona 2
Bom Despacho 2
Bracigliano 2
Buffalo 2
Caserta 2
Chengdu 2
Citta 2
Como 2
Corciano 2
Cornaredo 2
Duque de Caxias 2
Fayetteville 2
Fortaleza 2
Genoa 2
Gravatá 2
Hanoi 2
Hounslow 2
Isola della Scala 2
Itaquaquecetuba 2
Jinhua 2
Kagoya 2
Palagonia 2
Porto Alegre 2
Roseto degli Abruzzi 2
Totale 2.776
Nome #
Mismatch repair deficiency may affect clinical outcome through immune response activation in metastatic gastric cancer patients receiving first-line chemotherapy 152
The role of Aspirin as antitumoral agent for heavily pre-treated metastatic colorectal cancer patients receiving capecitabine monotherapy. BMC Cancer 144
The role of HER-3 expression in the prediction of clinical outcome for advanced colorectal cancer patients receiving irinotecan and cetuximab. 129
Angiogenesis genotyping and clinical outcome during regorafenib treatment in metastatic colorectal cancer patients 129
Impact of polypharmacy for chronic ailments in colon cancer patients: A review focused on drug repurposing. 125
Lgr5 expression, cancer stem cells and pancreatic cancer: Results from biological and computational analyses 124
Optimal management of resected gastric cancer 121
Clinical impact of different exosomes’ protein expression in pancreatic ductal carcinoma patients treated with standard first line palliative chemotherapy 120
The correlation between LDH serum levels and clinical outcome in advanced biliary tract cancer patients treated with first line chemotherapy 118
Acute Peripheral Motor Neuropathy Induced by Oxaliplatin-Correlated Hypokalaemia 111
KRAS mutation status is associated with specific pattern of genes expression in pancreatic adenocarcinoma 109
Toll like receptors and pancreatic diseases: From a pathogenetic mechanism to a therapeutic target 107
Prognostic clinical factors in pretreated colorectal cancer patients receiving regorafenib: Implications for clinical management 105
Clinical evidence for three distinct gastric cancer subtypes: time for a new approach. 99
HER family receptor expression and prognosis in pancreatic cancer 99
CANCER STEM CELL GENETIC PROFILE AS PREDICTOR OF RELAPSE IN RADICALLY RESECTED COLORECTAL CANCER 99
Medical treatment for cholangiocarcinoma 98
Phosphorylated AKT and MAPK expression in primary tumours and in corresponding metastases and clinical outcome in colorectal cancer patients receiving irinotecan-cetuximab. 96
Expression Profiling of Circulating Tumor Cells in Pancreatic Ductal Adenocarcinoma Patients: Biomarkers Predicting Overall Survival 96
VEGF and VEGFR polymorphisms affect clinical outcome in advanced renal cell carcinoma patients receiving first-line sunitinib 94
ASSOCIAZIONE TRA STATO MUTAZIONALE DI KRAS E PATTERN DI ESPRESSIONE GENETICA NEL CARCINOMA DEL PANCREAS 94
Pre-treatment lactate dehydrogenase levels as predictor of efficacy of first-line bevacizumab-based therapy in metastatic colorectal cancer patients. 94
Molecular biomarkers of resistance to anti-EGFR treatment in metastatic colorectal cancer, from classical to innovation. 93
The role of LDH serum levels in predicting global outcome in HCC patients undergoing TACE: implications for clinical management. 92
KRAS: To be or not to be targeted? Biologic and computational analyses in pancreatic adenocarcinoma 92
An observational retrospective analysis of the main metastatic site and corresponding locoregional treatment as a prognostic factor in metastatic gastric cancer 91
Role of vascular endothelial growth factor (VEGF) and VEGF-R genotyping in guiding the metastatic process in pT4a resected gastric cancer patients. 90
Role of β4 integrin in HER-3-negative, K-RAS wild-type metastatic colorectal tumors receiving cetuximab. 90
Panitumumab for the treatment of metastatic colorectal cancer: A review 86
Lactate Dehydrogenase in Hepatocellular Carcinoma: Something Old, Something New 85
Yes-associated protein and immunosuppressive microenvironment in pancreatic cancer development: A new strategy to improve immunotherapy efficacy? 85
Allele polymorphisms of tumor integrins correlate with peritoneal carcinosis capability of gastric cancer cells in radically resected patients. 84
Systemic immune-inflammation index: a prognostic tiebreaker among all in advanced pancreatic cancer 81
Angiogenesis genotyping in the selection of first-line treatment with either sunitinib or pazopanib for advanced renal cell carcinoma 79
The role of tumor vascular endothelial growth factor (VEGF) and vascular endothelial growth factor receptor (VEGFR) polymorphisms in the prediction of clinical outcome for advanced renal cell carcinoma patients receiving first-line sunitinib 78
Trattamento del carcinoma del pancreas. Attualità e prospettive 77
The challenge of targeted therapies for gastric cancer patients: The beginning of a long journey 75
Tumor angiogenesis genotyping and efficacy of first-line chemotherapy in metastatic gastric cancer patients. 74
Toward molecularly selected chemotherapy for advanced gastric cancer: state of the art and future perspectives. 73
Phase II study of pharmacogenetic-tailored therapy in elderly colorectal cancer patients. 73
Three drugs vs two drugs first-line chemotherapy regimen in advanced gastric cancer patients: a retrospective analysis 72
Doses of capecitabine and oral vinorelbine are not relevant for efficacy in breast cancer patients: an analysis of dose intensity. 70
Selecting the best treatment for an individual patient. 70
The Tower of Babel of liver metastases from colorectal cancer: Are we ready for one language? 64
Palliative treatment 62
Predictive factors for sunitinib treatment response in advanced renal cell carcinoma: are we really making steps forward? 57
Sicurezza degli ESA: sopravvivenza e stimolazione recettoriale/progressione tumorale 53
Retrospective Cohort Study of Caveolin-1 Expression as Prognostic Factor in Unresectable Locally Advanced or Metastatic Pancreatic Cancer Patients 48
Totale 4.457
Categoria #
all - tutte 23.860
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 23.860


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021872 49 84 114 36 110 59 62 59 72 105 80 42
2021/2022389 29 94 6 8 5 29 17 23 17 54 29 78
2022/2023854 60 117 59 62 62 141 1 46 193 10 80 23
2023/2024501 74 8 45 61 69 131 5 20 3 8 10 67
2024/2025987 148 77 20 21 64 49 99 35 162 71 133 108
2025/202656 56 0 0 0 0 0 0 0 0 0 0 0
Totale 4.457